Join Helena Biosciences to see the future of diagnostic automation. Alongside the company’s high-performance gel and capillary electrophoresis solutions for serum protein testing, it will be demonstrating the new Glyco Liver Profile.
This non-invasive test provides the clinician with a full picture of liver health (for inflammation, fibrosis, cirrhosis and hepatocellular carcinoma risk), regardless of aetiology – all from a single blood sample. Helena will also be demonstrating major upgrades to its automated haemoglobin products and new software capabilities for streamlining laboratory workflows.
To find out more visit Helena at Stand 931.